Cargando…
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
To make an optimal treatment decision for early stage breast cancer, it is important to identify risk of recurrence. Here, we developed and validated a new prognostic model for predicting the risk of distant metastasis in patients with pN0-N1, hormone receptor-positive, HER2-negative (HR+/HER2−) bre...
Autores principales: | Gong, Gyungyub, Kwon, Mi Jeong, Han, Jinil, Lee, Hee Jin, Lee, Se Kyung, Lee, Jeong Eon, Lee, Seon-Heui, Park, Sarah, Choi, Jong-Sun, Cho, Soo Youn, Ahn, Sei Hyun, Lee, Jong Won, Cho, Sang Rae, Moon, Youngho, Nam, Byung-Ho, Nam, Seok Jin, Choi, Yoon-La, Shin, Young Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368569/ https://www.ncbi.nlm.nih.gov/pubmed/28350001 http://dx.doi.org/10.1038/srep45554 |
Ejemplares similares
-
Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2021) -
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2018) -
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
por: Han, Jinil, et al.
Publicado: (2017) -
Prognostic Factors for Distant Metastasis in Patients with Locoregional Recurrence after Mastectomy
por: Jeong, Yuri, et al.
Publicado: (2015) -
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2019)